期刊
FRONTIERS IN MOLECULAR BIOSCIENCES
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fmolb.2022.936107
关键词
amblyomin-X; proteasome inhibitor; TFPI-like; antitumor; cytotoxic activity; bioactive molecule
资金
- Sao Paulo Research Foundation [2015/50040-4, 2020/13139-0]
- GlaxoSmithKline
- FAPESP-CETICs [2013/07467-1]
- CNPq-PQ [303197/2017-0]
- Fundacao Butantan-PQ
- FAPESP [2018/20469-7, 2018/10937-3]
Amblyomin-X is a recombinant protein that inhibits FXa and has anticoagulant, antiangiogenic, and antitumor properties. It induces apoptosis in cancer cells and promotes tumor regression through non-hemostatic mechanisms. It has selective cytotoxicity towards tumor cells and has potential as a novel anticancer drug.
Salivary glands are vital structures responsible for successful tick feeding. The saliva of ticks contains numerous active molecules that participate in several physiological processes. A Kunitz-type factor Xa (FXa) inhibitor, similar to the tissue factor pathway inhibitor (TFPI) precursor, was identified in the salivary gland transcriptome of Amblyomma sculptum ticks. The recombinant mature form of this Kunitz-type inhibitor, named Amblyomin-X, displayed anticoagulant, antiangiogenic, and antitumor properties. Amblyomin-X is a protein that inhibits FXa in the blood coagulation cascade and acts via non hemostatic mechanisms, such as proteasome inhibition. Amblyomin-X selectively induces apoptosis in cancer cells and promotes tumor regression through these mechanisms. Notably, the cytotoxicity of Amblyomin-X seems to be restricted to tumor cells and does not affect non-tumorigenic cells, tissues, and organs, making this recombinant protein an attractive molecule for anticancer therapy. The cytotoxic activity of Amblyomin-X on tumor cells has led to vast exploration into this protein. Here, we summarize the function, action mechanisms, structural features, pharmacokinetics, and biodistribution of this tick Kunitz-type inhibitor recombinant protein as a promising novel antitumor drug candidate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据